Anti-angiogenesis Therapy for Melanoma (Chapter 21)

Roberta Ferraldeschi, Paul Lorigan^*

^*Corresponding author for this work

Research output: Chapter in Book/Conference proceeding › Chapter › peer-review

Original language	English
Title of host publication	Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma
Publisher	Springer Nature
Chapter	21
Pages	281-294
Number of pages	14
ISBN (Electronic)	9781607614333
ISBN (Print)	9781607614326
DOIs	https://doi.org/10.1007/978-1-60761-433-3_21
Publication status	Published - 1 Jan 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@inbook{a1ad11a7de3643eca3144cdcd5b4b024,

title = "Anti-angiogenesis Therapy for Melanoma (Chapter 21)",

author = "Roberta Ferraldeschi and Paul Lorigan",

year = "2012",

month = jan,

day = "1",

doi = "10.1007/978-1-60761-433-3_21",

language = "English",

isbn = "9781607614326",

pages = "281--294",

booktitle = "Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma",

publisher = "Springer Nature",

address = "United States",

}

TY - CHAP

T1 - Anti-angiogenesis Therapy for Melanoma (Chapter 21)

AU - Ferraldeschi, Roberta

AU - Lorigan, Paul

PY - 2012/1/1

Y1 - 2012/1/1

UR - http://www.scopus.com/inward/record.url?scp=85028893949&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-433-3_21

DO - 10.1007/978-1-60761-433-3_21

M3 - Chapter

AN - SCOPUS:85028893949

SN - 9781607614326

SP - 281

EP - 294

BT - Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma

PB - Springer Nature

ER -